Incannex Healthcare IXHL Stock
Incannex Healthcare Price Chart
Incannex Healthcare IXHL Financial and Trading Overview
| Incannex Healthcare stock price | 0.22 USD |
| Previous Close | 0.2 USD |
| Open | 0.21 USD |
| Bid | 0.16 USD x 200 |
| Ask | 0.27 USD x 200 |
| Day's Range | 0.21 - 0.23 USD |
| 52 Week Range | 0.08 - 3.12 USD |
| Volume | 19.65M USD |
| Avg. Volume | 58.18M USD |
| Market Cap | 20.21M USD |
| Beta (5Y Monthly) | 2.469 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.23 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
IXHL Valuation Measures
| Enterprise Value | 959.89K USD |
| Trailing P/E | N/A |
| Forward P/E | -0.11005102 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 206.2255 |
| Price/Book (mrq) | 0.8018588 |
| Enterprise Value/Revenue | 9.795 |
| Enterprise Value/EBITDA | -0.047 |
Trading Information
Incannex Healthcare Stock Price History
| Beta (5Y Monthly) | 2.469 |
| 52-Week Change | -93.11% |
| S&P500 52-Week Change | 12.74% |
| 52 Week High | 3.12 USD |
| 52 Week Low | 0.08 USD |
| 50-Day Moving Average | 0.27 USD |
| 200-Day Moving Average | 1.32 USD |
IXHL Share Statistics
| Avg. Volume (3 month) | 58.18M USD |
| Avg. Daily Volume (10-Days) | 20.43M USD |
| Shares Outstanding | 93.7M |
| Float | 28.23M |
| Short Ratio | 0.05 |
| % Held by Insiders | 26.13% |
| % Held by Institutions | 8.28% |
| Shares Short | 4.92M |
| Short % of Float | 5.50% |
| Short % of Shares Outstanding | 5.26% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2024 |
| Most Recent Quarter (mrq) | March 31, 2025 |
| Next Fiscal Year End | June 30, 2025 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -20952.042% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -76.73% |
| Return on Equity (ttm) | -201.87% |
Income Statement
| Revenue (ttm) | 98K USD |
| Revenue Per Share (ttm) | 0.005 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 98K USD |
| EBITDA | -20286000 USD |
| Net Income Avi to Common (ttm) | -21743000 USD |
| Diluted EPS (ttm) | -1.23 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 6.71M USD |
| Total Cash Per Share (mrq) | 0.23 USD |
| Total Debt (mrq) | 1.69M USD |
| Total Debt/Equity (mrq) | 22.79 USD |
| Current Ratio (mrq) | 2.121 |
| Book Value Per Share (mrq) | 0.269 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -14673000 USD |
| Levered Free Cash Flow (ttm) | -6954500 USD |
Profile of Incannex Healthcare
| Country | United States |
| State | NSW |
| City | Sydney |
| Address | 8 Century Circuit |
| ZIP | 2153 |
| Phone | 61 4 0984 0786 |
| Website | https://www.incannex.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 9 |
Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research, development, manufacture, sale, and distribution of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that has completed Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treatment in Phase 2b clinical development for patients with generalized anxiety disorder. It is also developing IHL-675A, an oral fixed dose combination drug containing synthetic cannabidiol and hydroxychloroquine sulphate in Phase 2 clinical trial to treat rheumatoid arthritis, as well as lung inflammation, acute respiratory disease, chronic obstructive pulmonary disease, asthma, bronchitis, inflammatory bowel disease, colitis, and Crohn's disease. Incannex Healthcare Inc. is headquartered in Sydney, Australia.
Q&A For Incannex Healthcare Stock
What is a current IXHL stock price?
Incannex Healthcare IXHL stock price today per share is 0.22 USD.
How to purchase Incannex Healthcare stock?
You can buy IXHL shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Incannex Healthcare?
The stock symbol or ticker of Incannex Healthcare is IXHL.
Which industry does the Incannex Healthcare company belong to?
The Incannex Healthcare industry is Drug Manufacturers - Specialty & Generic.
How many shares does Incannex Healthcare have in circulation?
The max supply of Incannex Healthcare shares is 93.7M.
What is Incannex Healthcare Price to Earnings Ratio (PE Ratio)?
Incannex Healthcare PE Ratio is now.
What was Incannex Healthcare earnings per share over the trailing 12 months (TTM)?
Incannex Healthcare EPS is -1.23 USD over the trailing 12 months.
Which sector does the Incannex Healthcare company belong to?
The Incannex Healthcare sector is Healthcare.
Incannex Healthcare IXHL included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 20369.73 USD — |
+0.47
|
7.5B USD — | 20266.36 USD — | 20418.31 USD — | — - | 7.5B USD — |
| NASDAQ Global Market Composite NQGM | 2024.67 USD — |
+0.58
|
— — | 2021.07 USD — | 2032.63 USD — | — - | — — |
| Nasdaq Health Care IXHC | 963.13 USD — |
+0.37
|
— — | 959.01 USD — | 964.99 USD — | — - | — — |
- {{ link.label }} {{link}}